/
/
/

Aurobindo Pharma Balance Sheet

Consolidated
Standalone
₹
%

Share Price Live Stats

Open (₹)1,677.90
Volume (₹)7.97 L
High (₹)1,681.70
Upper Circuit1,710.30
Low (₹)1,655.00
Lower Circuit1,610.70
Prev Close1,677.90
52W High (₹)1,740.00
Price1,666.90
52W Low (₹)1,080.10

Share Market Cap & Key Ratios Overview

M.Cap (₹)96375.80 Cr
Div. Yield (%)0.24
PE Ratio25.96
Debt to Equity0.20
Price to Book2.00
Book Value652.39
EPS (TTM)64.52
Face Value1.00
ROE (%)9.93

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
LTP
1W Low
1W High
Market cap (₹)
1758.8-1.2 (-0.07%)
1725.50
1778
4,22,427Cr
9144.5-195.5 (-2.09%)
8937.50
9431.50
2,39,982Cr
4558.9-98 (-2.10%)
4550.40
4682
1,75,196Cr
1123+5.5 (0.49%)
1107.30
1150.90
1,13,790Cr
2060.1+23.5 (1.15%)
2007.80
2086
1,09,143Cr
1325.1+24.1 (1.85%)
1300.20
1337.50
1,07,746Cr
1233+36 (3.01%)
1196.90
1250.70
1,01,894Cr
2275.5-93 (-3.93%)
2268.70
2426.80
97,264Cr
1666.9-26.1 (-1.54%)
1647.10
1715
96,376Cr
1961.6+5.1 (0.26%)
1925.70
1990.90
89,592Cr

Key Highlights of Aurobindo Pharma Ltd Balance Sheet

Aurobindo Pharma Ltd balance sheet discloses shareholders' funds of ₹58.08Cr as of 2026-03-31. The company’s equity share capital is at a value of ₹58.08Cr, and the reserves and surplus of the company is ₹22659.6Cr.

The company has its non-current liabilities with total liabilities of ₹34416.9Cr as of 2026-03-31.

The current liabilities are ₹6992.44Cr as of 2026-03-31. At the same time, current assets are ₹8714.97Cr as of 2026-03-31.

Key assets on the balance sheet are non-current investments of ₹16836.2Cr and tangible assets of ₹2543.73Cr, provided in the Aurobindo Pharma Ltd financial statements.